Chugai Pharmaceutical Co., Ltd. (CUP0)
Munich
Closed
Oct 8, 2026
Day's Range
17.5052 wk Range
17.50Overview - CUP0 - Chugai Pharmaceutical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
-5.01B
P/E (Trailing)
‪21.87‬
Price / Sales (TTM)
‪0.04‬
Price / Book
‪5.04‬
EV / EBITDA
‪-1.31‬
Profitability
Profit Margin
‪35.10%‬
Operating Margin
‪47.09%‬
Return on Assets
‪17.05%‬
Return on Equity
‪23.49%‬
Ownership
Shares Outstanding
1.64B
Float
1.27B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.05%‬
Price stats
Beta
‪0.56‬
50-Day Avg
‪18.66‬
200-Day Avg
‪21.69‬
Dividends
Payout Ratio
‪48.40%‬
Frequency
Semi-Annual
Market Cap - CUP0 - Chugai Pharmaceutical Co., Ltd.
Peers - CUP0 - Chugai Pharmaceutical Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Munich.
- CUP0MunichChugai Pharmaceutical Co., Ltd.57.59BMarket Cap-18.86%52-week change21.88P/E (Trailing)‪35.10%‬Profit Margin
- RHOAMunichRoche Holding AG290.82BMarket Cap-0.22%52-week change20.98P/E (Trailing)‪20.33%‬Profit Margin
- ON4MunichOno Pharmaceutical Co. Ltd.6.31BMarket Cap+28.15%52-week change16.38P/E (Trailing)‪15.11%‬Profit Margin
- SZD0MunichSanten Pharmaceutical Co., Ltd.3.08BMarket Cap+3.13%52-week change15.24P/E (Trailing)‪13.25%‬Profit Margin
Profile Summary - CUP0 - Chugai Pharmaceutical Co., Ltd.
About
Chugai Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacturing, and sale of innovative medicines. The primary purpose of Chugai Pharmaceutical is to address the unmet medical needs across various therapeutic fields, with a strong emphasis on…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
